Hepatocellular carcinoma (HCC) is one of the top 10 malignancies with a high mortality worldwide. Although liver transplantation, surgical resection, and image-guided ablation currently stand as the most effective treatment options for early-stage HCC, drug-based therapeutic options are limited.1